Signal transduction inhibitors in treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis that results in reduced blood counts. Although MDS can transform into leukemia, most of the morbidity experienced by these patients is due to chronically low blood counts. Conventional cyt...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bachegowda, Lohith, Gligich, Oleg, Mantzaris, Ionnis, Schinke, Carolina, Wyville, Dale, Carrillo, Tatiana, Braunschweig, Ira, Steidl, Ulrich, Verma, Amit
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716523/
https://ncbi.nlm.nih.gov/pubmed/23841999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-50
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki